학술논문

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
Document Type
Article
Source
In: npj Breast Cancer. (npj Breast Cancer, December 2021, 7(1))
Subject
Language
English
ISSN
23744677